These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 9209817

  • 1. Ergogenic drugs in sports.
    Knopp WD, Wang TW, Bach BR.
    Clin Sports Med; 1997 Jul; 16(3):375-92. PubMed ID: 9209817
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Cardiovascular complications of doping products].
    Demoulin R, Poyet R, Capilla E, Tortat AV, Pons F, Brocq FX, Druelle A, Jego C, Foucault G, Cellarier GR.
    Ann Cardiol Angeiol (Paris); 2018 Nov; 67(5):365-369. PubMed ID: 30290907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The use of drugs to improve athletic performance].
    Kuipers H, Hartgens F.
    Ned Tijdschr Geneeskd; 1997 Oct 11; 141(41):1965-8. PubMed ID: 9550746
    [Abstract] [Full Text] [Related]

  • 10. Ergogenic aids.
    Thein LA, Thein JM, Landry GL.
    Phys Ther; 1995 May 11; 75(5):426-39. PubMed ID: 7732086
    [Abstract] [Full Text] [Related]

  • 11. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM, Diallo B, Fall A, Ndiaye M, Cissè F, Faye B.
    Sante; 2005 May 11; 15(3):167-70. PubMed ID: 16207578
    [Abstract] [Full Text] [Related]

  • 12. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H, Simon P, Frisch S, Roecker K, Dietz K, Dickhuth HH, Ulrich R.
    Drug Alcohol Depend; 2006 Jan 04; 81(1):11-9. PubMed ID: 16009506
    [Abstract] [Full Text] [Related]

  • 13. Performance-enhancing drugs, fair competition, and Olympic sport.
    Catlin DH, Murray TH.
    JAMA; 1996 Jul 17; 276(3):231-7. PubMed ID: 8667569
    [Abstract] [Full Text] [Related]

  • 14. [Doping agents and their analytical control].
    Szókán G.
    Acta Pharm Hung; 2002 Jul 17; 72(4):231-44. PubMed ID: 12812043
    [Abstract] [Full Text] [Related]

  • 15. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M, Schänzer W.
    Mass Spectrom Rev; 2007 Jul 17; 26(1):79-107. PubMed ID: 16888758
    [Abstract] [Full Text] [Related]

  • 16. Analytical strategy for detecting doping agents in hair.
    Thieme D, Grosse J, Sachs H, Mueller RK.
    Forensic Sci Int; 2000 Jan 10; 107(1-3):335-45. PubMed ID: 10689585
    [Abstract] [Full Text] [Related]

  • 17. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop NM, Pigozzi F, Schänzer W, Vanhees L, ESC Study Group of Sports Cardiology.
    Eur J Cardiovasc Prev Rehabil; 2006 Oct 10; 13(5):687-94. PubMed ID: 17001206
    [Abstract] [Full Text] [Related]

  • 18. [Sports and doping].
    Yoshida T.
    Chudoku Kenkyu; 2003 Jul 10; 16(3):299-305. PubMed ID: 14582352
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.